Safety Lancet Market Outlook Signals Expansion To $3.3 Billion Through 2030

The safety lancet market is on track for significant growth in the upcoming years, driven by increasing demand for safer and more efficient blood sampling devices. As healthcare continues to emphasize preventive measures and improved diagnostics, this sector is set to experience robust expansion through 2030.

Forecasting Safety Lancet Market Size and Expansion by 2030
The safety lancet market is projected to reach a valuation of $3.3 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.9%. This anticipated growth is supported by several factors, such as the rise in home diagnostic testing, an increasing burden of chronic diseases worldwide, tougher occupational safety laws, and the growing use of point-of-care testing. Additionally, the trend toward preventive healthcare screenings is playing a vital role in propelling demand within this market.

Download a free sample of the Safety Lancet market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20620&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Primary Factors Fueling Safety Lancet Market Growth
One of the key drivers behind the safety lancet market's upward trajectory is the rising adoption of safety-engineered blood collection devices. These devices are favored for their ability to lower the risk of needlestick injuries, thereby protecting healthcare workers and patients alike.
Another contributing factor is the growing preference for single-use disposable lancets, which offer enhanced hygiene and reduce the possibility of cross-contamination. Furthermore, an increased emphasis on needlestick injury prevention and expanding applications for point-of-care testing are adding momentum to this market segment.

Top Companies Advancing the Safety Lancet Industry
The market features several prominent companies leading innovation and supply, including McKesson Corporation, Cardinal Health Inc., F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medline Industries Inc., Becton dic*kinson and Company, B. Braun SE, Terumo Medical Corporation, Nipro Corporation, Sarstedt AG & Co. KG., Greiner Bio-One International GmbH, Ypsomed Holding AG, Improve Medical Technology Co. Ltd, Omron Healthcare Inc., Owen Mumford Ltd., Arkray Inc., AgaMatrix Inc., Narang Medical Limited., DarioHealth Corp, HTL-STREFA S.A., Ribbel International Limited, Simple Diagnostics Inc., Sara Healthcare Private Limited, Smiths Medical, and Sterimed Group.

View the full Safety Lancet market report:
https://www.thebusinessresearchcompany.com/report/safety-lancet-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Strategic Moves in the Safety Lancet Sector Highlighted by Recent Acquisitions
A notable development occurred in August 2024, when Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device firm, acquired the pen needle and blood glucose monitoring (BGM) business from Ypsomed Holding AG. This acquisition is aimed at broadening MTD's diabetes care offerings, strengthening its presence in the global insulin delivery and monitoring market, and integrating Ypsomed's existing product lines to provide comprehensive diabetes management solutions. Ypsomed Holding AG, based in Switzerland, is known for manufacturing medical devices including safety lancets.

Emerging Innovations Redefining Safety Lancet Technology
Market leaders are focusing on creating advanced devices like heel lancets to improve safety and precision in infant blood sampling. Heel lancets are small, pointed instruments designed for heel puncture, commonly used in newborn screening and diabetes testing.
For example, in October 2023, UK-based Owen Mumford introduced the Unistik Heelstik line, which offers neonatal and pediatric capillary blood sampling devices with enhanced safety features. These devices aim to reduce infant discomfort during blood collection and lower needlestick injury risks for healthcare professionals.

Detailed Segmentation of the Safety Lancet Market
This report divides the safety lancet market into several key segments:
1) By Product Type: Push Button Safety Lancet, Pressure Activated Safety Lancet, and Side Button Safety Lancet
2) By Application: Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, and Coagulation Testing
3) By End-User: Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, and Other End-Users

Further breakdown within product categories includes:
- Push Button Safety Lancets: Manual, Automatic, and Adjustable Depth variants
- Pressure Activated Safety Lancets: Single-Use, Multi-Use, and Adjustable Pressure models
- Side Button Safety Lancets: Standard, Ergonomic, and Adjustable Depth options

This segmentation highlights the diverse product offerings and broad applicability of safety lancets across various healthcare settings and testing requirements.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.